WebDec 1, 2016 · 58.2 mg of argatroban; 288 mg of bivalirudin; 7.5 mg of fondaparinux; Drug costs were based on those observed at the Banner-University Medical Center in Tucson, Arizona, where a 250 mg/2.5 mL vial of argatroban costs $331; a 250 mg/5 mL vial of bivalirudin costs $418; and a 7.5 mg prefilled syringe of fondaparinux costs $32.72. WebBivalirudin is a member of the thrombin inhibitors drug class and is commonly used for Angina, and Percutaneous Coronary Intervention. Brand names for bivalirudin include Angiomax . The cost for bivalirudin intravenous powder for injection 250 mg is around … Drugs.com provides accurate and independent information on more than … Usual Adult Dose for Angina Pectoris. For patients who do not have heparin … Bivalirudin. Generic name: bivalirudin [ bye-VAL-i-roo-din ] Brand name: Angiomax …
HIT or Miss? Comparing Cost-Effectiveness of Fondaparinux, …
WebAt UWMC, bivalirudin is monitored using the Direct Thrombin Inhibitor (DTI) assay (Plasma-Diluted Thrombin Time). Used instead of aPTT to monitor injectable DTI … WebBivalirudin 250 mg injection is a medication used as an anticoagulant (blood thinner) in patients undergoing certain medical procedures, such as percutaneous coronary … robert luth arrest
Bivalirudin Prices, Coupons, Copay & Patient Assistance
WebAngiomax (bivalirudin) is a member of the thrombin inhibitors drug class and is commonly used for Angina, and Percutaneous Coronary Intervention. The cost for Angiomax … Webphial costs £4.20, a bivalirudin 250 mg/5 mL phial costs £372, a 12.5 mg/50 mL tirofiban phial costs £146.10 and a 10 mg/5 mL abciximab phial costs £265.60. The other antithrombotic costs were assumed to be negligible and equal for all agents. We aimed to define the cost of antithrombotic agents associated with the PPCI index procedure. WebJan 15, 2016 · Additionally, there were non-significant trends towards high use of warfarin in patients treated with bivalirudin. Data from the BRAVO study demonstrated that patients who received bivalirudin had lower rates of in-hospital BARC ≥3 major bleeding (4.9% vs. 13.2%, p=0.003), as well as lower rates of NACE (11.2% vs. 20.1%, p=0.01). 9 However ... robert lustig real food